Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China.

Han J, Pan Y, Chen Y, Li X, Xing G, Shi J, Hou P, Zhang H, Wang H.

Nephron Clin Pract. 2010;114(4):c260-7. doi: 10.1159/000276578. Epub 2010 Jan 20.

PMID:
20090368
2.

A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.

Chen S, Liu ZH, Zheng JM, Zhang X, Li LS.

J Nephrol. 2007 Sep-Oct;20(5):568-75.

PMID:
17918142
3.

Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.

Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Zhou H, Li LS.

Chin Med J (Engl). 2005 Apr 5;118(7):555-60.

PMID:
15820086
4.

A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.

Bomback AS, Song H, D'Agati VD, Cohen SD, Neal A, Appel GB, Rovin BH.

Nephrol Dial Transplant. 2010 Oct;25(10):3442-6. doi: 10.1093/ndt/gfq389. Epub 2010 Jul 11.

PMID:
20624773
5.

A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.

Mitani A, Ishigami M, Watase K, Minakata T, Yamamura T.

J Atheroscler Thromb. 2011;18(6):531-5. Epub 2011 Feb 16.

6.

Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.

Saito T, Ishigaki Y, Oikawa S, Yamamoto TT.

Trends Cardiovasc Med. 2002 Feb;12(2):67-70. Review.

PMID:
11852253
7.

Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.

Saito T, Matsunaga A, Oikawa S.

Am J Kidney Dis. 2006 Feb;47(2):199-211. Review.

PMID:
16431249
8.

Lipoprotein glomerulopathy in China.

Chen Y.

Clin Exp Nephrol. 2014 Apr;18(2):218-9. doi: 10.1007/s10157-013-0873-x. Epub 2013 Oct 29. Review.

PMID:
24165683
9.

APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy.

Rovin BH, Roncone D, McKinley A, Nadasdy T, Korbet SM, Schwartz MM.

N Engl J Med. 2007 Dec 13;357(24):2522-4. No abstract available.

10.

Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.

Luo B, Huang F, Liu Q, Li X, Chen W, Zhou SF, Yu X.

Am J Nephrol. 2008;28(2):347-53. Epub 2007 Nov 29.

11.

Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.

Saito T, Oikawa S, Sato H, Sato T, Ito S, Sasaki J.

Kidney Int Suppl. 1999 Jul;71:S37-41.

PMID:
10412734
12.

[Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].

Han HL, Lin S, Sun LS, Zhang P, Zhai DP.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Apr;29(2):141-4. doi: 10.3760/cma.j.issn.1003-9406.2012.02.005. Chinese.

PMID:
22487820
13.

A rare case of lipoprotein glomerulopathy in a white man: an emerging entity in Asia, rare in the white population.

Boumendjel R, Papari M, Gonzalez M.

Arch Pathol Lab Med. 2010 Feb;134(2):279-82. doi: 10.1043/1543-2165-134.2.279.

PMID:
20121619
14.

Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.

Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Li LS.

J Nephrol. 2008 Jan-Feb;21(1):110-7. Erratum in: J Nephrol. 2008 May-Jun;21(3):446.

PMID:
18264944
15.

Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.

Ishimura A, Watanabe M, Nakashima H, Ito K, Miyake K, Mochizuki S, Ishigaki Y, Saito T.

Clin Exp Nephrol. 2009 Oct;13(5):430-7. doi: 10.1007/s10157-009-0195-1. Epub 2009 May 21.

PMID:
19459027
16.

[A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients].

Chen YQ, Zhang H, Zhu SL, Zou WZ, Wang M, Liu ZS, Wang HY.

Zhonghua Yi Xue Za Zhi. 2003 May 10;83(9):774-7. Chinese.

PMID:
12899757
17.

Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.

Sam R, Wu H, Yue L, Mazzone T, Schwartz MM, Arruda JA, Dunea G, Singh AK.

Am J Kidney Dis. 2006 Mar;47(3):539-48. Review.

PMID:
16490634
18.

Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.

Oikawa S, Matsunaga A, Saito T, Sato H, Seki T, Hoshi K, Hayasaka K, Kotake H, Midorikawa H, Sekikawa A, Hara S, Abe K, Toyota T, Jingami H, Nakamura H, Sasaki J.

J Am Soc Nephrol. 1997 May;8(5):820-3.

19.

Significance of a novel apolipoprotein E variant, ApoE Osaka/Kurashiki, in lipoprotein glomerulopathy.

Saito T, Matsunaga A.

J Atheroscler Thromb. 2011;18(6):542-3. Epub 2011 Jun 13. No abstract available.

20.

Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.

Chang CF, Lin CC, Chen JY, Yang AH, Shiao MS, Kao JT, Yang WC.

Am J Kidney Dis. 2003 Sep;42(3):E18-23.

PMID:
12955707

Supplemental Content

Support Center